Amgen (AMGN) Non-Current Assets (2009 - 2026)

Amgen has reported Non-Current Assets for 18 years, with the latest figure at $60.7 billion in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 0.79% year-over-year to $60.7 billion in Q2 2026; TTM through Jun 2026 was $245.5 billion, a 2.01% decrease from a year earlier, with the FY2025 full-year figure at $61.5 billion, down 2.04% from the prior year.
• Non-Current Assets was $60.7 billion for Q2 2026 at Amgen, down from $61.0 billion in the prior quarter.
• The five-year high for Non-Current Assets was $66.8 billion in Q4 2023, with the low at $39.6 billion in Q3 2022.
• Average Non-Current Assets over 5 years is $54.6 billion, with a median of $61.1 billion recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Non-Current Assets jumped 55.64% in 2023, then fell 6.01% in 2024.
• Over 5 years, Non-Current Assets stood at $42.9 billion in 2022, then surged by 55.64% to $66.8 billion in 2023, then decreased by 6.01% to $62.8 billion in 2024, then retreated by 2.04% to $61.5 billion in 2025, then declined by 1.38% to $60.7 billion in 2026.
• The last three Non-Current Assets figures came in at $60.7 billion (Q2 2026), $61.0 billion (Q1 2026), and $61.5 billion (Q4 2025), per Business Quant data.